- About
- PsychU For You
- Topics
- Events
- Content
Addressing Inequalities In Agitation Among Disinvested Communities With Alzheimer’s Disease
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Addressing Inequalities In Agitation Among Disinvested Communities With Alzheimer’s Disease
Agitation is a complex and challenging neuropsychiatric symptom in Alzheimer’s disease1, and it is associated with increased economic, healthcare, individual, and care partner burden. Unfortunately, agitation associated with Alzheimer’s disease is highly prevalent and poses significant challenges in accessing effective care, particularly for individuals from disinvested and underrepresented ethnicities. The expression of agitation associated with Alzheimer’s Disease is increasing in minority older adults, exacerbating these challenges2. Agitation in Alzheimer’s Disease is associated with increased economic, healthcare, individual, and care partner burden as well.3 In this webinar, our expert speaker will explore the barriers to treatment access and challenges faced by the medical community in delivering equitable care to agitated individuals with Alzheimer’s Disease from diverse backgrounds.
References:- Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015). Assessment and management of behavioral and psychological symptoms of dementia. BMJ (Clinical research ed.), https://doi.org/10.1136/bmj.h369
- Babulal, G. M., & Quiroz, Y. T. (2019). Perspectives on ethnic and racial disparities in Alzheimer’s disease and related dementias: Update and areas of immediate need. Alzheimer’s & Dementia, 15(2), 292-312. https://doi.org/10.1016/j.jalz.2018.09.009
- Anatchkova, M., & Brooks, A. (2019). Agitation in patients with dementia: a systematic review of epidemiology and association with severity and course. International Psychogeriatrics, 31(9), 1305–1318. https://doi.org/10.1017/S1041610218001898
April D. Thames, Ph.D.
Professor of Psychiatry, Chief Psychologist of Adult Division (Psychology) at UCLA Department of Psychiatry and Biobehavioral Sciences
John Awad, MD (OPDC)
Senior Medical Science Liaison
Nneka Okonkwor, PharmD, MBA (OPDC)
Medical Science Liaison
April D. Thames, Ph.D., is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
John Awad, MD and Nneka Okonkwor, PharmD, MBA, are paid employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
US.CORP.X.23.00232Registration
- PsychU For You
